Crinetics Pharmaceuticals Inc. (CRNX)
NASDAQ · Healthcare
Crinetics Pharmaceuticals Inc. Revenue 2016–2025
Crinetics Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Crinetics Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 10.7 M, a 2873.41% increase year-over-year.
- Crinetics Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 12.3 M, a 785.85% increase year-over-year.
- Crinetics Pharmaceuticals Inc. annual revenue for 2025 was 7.7 M, a 640.71% increase from 2024.
- Crinetics Pharmaceuticals Inc. annual revenue for 2024 was 1.0 M, a 74.11% decrease from 2023.
- Crinetics Pharmaceuticals Inc. annual revenue for 2023 was 4.0 M.
- Crinetics Pharmaceuticals Inc. annual revenue for 2022 was 0.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Crinetics Pharmaceuticals Inc. Earnings — FAQ
Crinetics Pharmaceuticals Inc. (CRNX) earnings over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRNX's earnings history?
The chart and table above show Crinetics Pharmaceuticals Inc.'s earnings by year and by quarter, including the growth rate.